Cita APA

Venturutti, L., Cordo Russo, R. I., Rivas, M. A., Mercogliano, M. F., Izzo, F., Oakley, R. H., . . . Elizalde, P. V. (2016). MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. Web

Citación estilo Chicago

Venturutti, Leandro, et al. MiR-16 Mediates Trastuzumab and Lapatinib Response in ErbB-2-positive Breast and Gastric Cancer Via Its Novel Targets CCNJ and FUBP1. 2016.

Cita MLA

Venturutti, Leandro, et al. MiR-16 Mediates Trastuzumab and Lapatinib Response in ErbB-2-positive Breast and Gastric Cancer Via Its Novel Targets CCNJ and FUBP1. 2016.